IP Library Granted Patent US 6,939,564
Granted Patent B2
US 6,939,564 · App. 09/877,999 · Granted Sep 6, 2005

Water-soluble stabilized self-assembled polyelectrolytes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,564
App. No.
09/877,999
Granted
Sep 6, 2005
Kind
B2
Abstract

The present invention is directed toward water-soluble supramolecular self-assemblies and a process for their preparation via micellization of polyelectrolytes through the use of hydrophobic monomeric units. In this invention the polyelectrolyte segment ultimately forms the core of the supramolecular assembly whereas the shell consists of uncharged hydrophilic polymers or oligomers. It has been determined that the inclusion of the hydrophobic co-monomers to the polyelectrolyte segment forming the micelle core leads to a structure of enhanced stability.

Claims (25)

1. Multimolecular micelles consisting essentially of polyelectrolyte copolymers including at least one hydrophobic block and at least one hydrophilic block wherein:

1) said at least one hydrophobic block comprises ionizable and/or charged repeating monomers in combination with nonionic hydrophobic repeating monomers; wherein the ionizable and/or charged repeating monomers include at least one compound selected from the group consisting of alkylacrylic acid derivatives, acrylic acid derivatives, aminoalkylacrylate derivatives, and (amino alkyl) alkylacrylate derivatives, and wherein the non-ionic hydrophobic repeating monomers include one or more hydrophobic vinyl compounds; and

2) said at least one hydrophilic block, comprises a nonionic hydrophilic polymer or oligomer that is polyethylene glycol or that is synthesized from hydrophilic vinyl monomers; and

wherein said hydrophobic block comprising ionizable and/or charged repeating monomers in combination with the nonionic hydrophobic repeating monomers forms a micellar core and said hydrophilic block forms the exterior of the micelle.

2. The multimolecular micelles of claim 1 wherein each said polyelectrolyte copolymer is a graft copolymer wherein:

1) said hydrophobic block serves as a backbone to which said hydrophilic polymers or oligomers are grafted, wherein said hydrophobic block comprises ionizable and permanently-charged amphiphilic random copolymers including at least one compound selected from the group consisting of alkylacrylic acid derivatives, acrylic acid derivatives, aminoalkylacrylate derivatives, and (amino alkyl) alkylacrylate derivatives in combination with said nonionic hydrophobic repeating monomers; or

2) said hydrophilic block serves as a backbone to which one or more hydrophobic blocks of claim 1 are grafted.

3. The multimolecular micelle of claim 1 wherein:

said one or more hydrophobic vinyl compounds are selected from the group consisting of acrylates, acrylamides, alkylacrylates, alkylacrylamides, arylacrylates, and arylacrylamides.

4. The multimolecular micelle of claim 3 wherein:

said one or more hydrophobic vinyl compounds comprise at least one aliphatic or aromatic moiety selected from the group consisting of methacrylates and methacrylamides.

5. The multimolecular micelle of claim 3 wherein:

said hydrophobic repeating monomers form at least one vinyl-terminated biodegradable polyester.

6. The multimolecular micelle of claim 1 wherein:

said at least one hydrophilic block comprises at least one repeating unit selected from the group consisting of acrylates, acrylamides, alkylacrylates, alkylacrylamides, and N-vinyl-2-pyrrolidones.

7. The multimolecular micelles of claim 6 , wherein:

said hydrophilic block originates from a macroinitiator comprising a poly(ethylene glycol) or a poly (N-vinyl-2-pyrrolidone).

8. The multimolecular micelle of claim 2 wherein:

said one or more hydrophobic vinyl compounds are selected from the group consisting of acrylates, acrylainides, alkylacrylates, alkylacrylamides, arylacrylates, and arylacrylamides.

9. The multimolecular micelle of claim 8 wherein:

said one or more hydrophobic vinyl compounds comprise at least one aliphatic or aromatic moiety selected from the group consisting of methacrylates and methacrylamides.

10. The multimolecular micelle of claim 8 wherein:

said hydrophobic repeating monomers form at least one vinyl terminated biodegradable polyester.

11. The multimolecular micelle of claim 2 wherein:

said hydrophilic vinyl monomers are selected from the group consisting of acrylates, acrylamides, alkylacrylates, alkylacrylamides, and N-vinyl-2-pyrrolidones.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067221/0958 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED; PALADIN LABS INC.
Reel/Frame 067216/0376 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
CHANGE OF NAME Recorded Mar 21, 2013
From: LABOPHARM (BARBADOS) LIMITED
To: PALADIN LABS (BARBADOS) INC.
Reel/Frame 030060/0875 →
MERGER Recorded Mar 21, 2013
From: LABOPHARM INC.
To: PALADIN LABS INC.
Reel/Frame 030062/0821 →
MERGER Recorded Mar 21, 2013
From: PALADIN LABS (BARBADOS) INC. (COMPANY #30304); LABOPHARM (BARBADOS) LIMITED (COMPANY # 21899)
To: LABOPHARM (BARBADOS) LIMITED (COMPANY # 36646)
Reel/Frame 030060/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2013
From: LABOPHARM INC.
To: CHIMIGEN INC.
Reel/Frame 030060/0673 →
CHANGE OF NAME Recorded Mar 21, 2013
From: CHIMIGEN INC.
To: LABOPHARM INC.
Reel/Frame 030060/0739 →
CHANGE OF NAME Recorded Mar 21, 2013
From: LABOPHARM EUROPE LIMITED
To: PALADIN LABS EUROPE LIMITED
Reel/Frame 030060/0785 →
CHANGE OF ADDRESS FOR ASSIGNEE (SEE #2) Recorded Dec 2, 2010
From: LABOPHARM (BARBADOS) LIMITED
To: LABOPHARM (BARBADOS) LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 025381/0533 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE INFORMATION PREVIOUSLY RECORDED ON REEL 021387 FRAME 0516. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF THE ASSIGNOR'S INTEREST. Recorded Jan 15, 2009
From: LABOPHARM INC.
To: LABOPHARM EUROPE LIMITED - PARTIAL INTEREST (ENTIRE INTEREST OWNED BY LABOPHARM INC., LABOPHARM EUROPE LIMITED, AND LABOPHARM (BARBADOS) LIMITED); LABOPHARM (BARBADOS) LIMITED - PARTIAL INTEREST (ENTIRE INTEREST OWNED BY LABOPHARM INC., LABOPHARM EUROPE LIMITED, AND LABOPHARM (BARBADOS) LIMITED)
Reel/Frame 022109/0279 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2008
From: LABOPHARM INC.
To: LABOPHARM EUROPE LIMITED; LABOPHARM (BARBADOS) LIMITED
Reel/Frame 021387/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2001
From: RANGER, MAXIME; LEROUX, JEAN-CHRISTOPHE
To: LABOPHARM, INC.
Reel/Frame 011891/0112 →